OrthoPediatrics (NASDAQ:KIDS) Sets New 52-Week Low - Should You Sell?

OrthoPediatrics Corp. (NASDAQ:KIDS - Get Free Report) shares hit a new 52-week low during mid-day trading on Monday . The company traded as low as $21.99 and last traded at $21.99, with a volume of 210 shares traded. The stock had previously closed at $22.93.

Analysts Set New Price Targets

A number of research analysts have weighed in on KIDS shares. Truist Financial cut their price objective on shares of OrthoPediatrics from $34.00 to $28.00 and set a "hold" rating on the stock in a research report on Monday, October 14th. Needham & Company LLC reissued a "buy" rating and issued a $42.00 price objective on shares of OrthoPediatrics in a research report on Friday, November 8th. Finally, JMP Securities restated a "market outperform" rating and set a $50.00 target price on shares of OrthoPediatrics in a research report on Friday, September 13th.

OrthoPediatrics Price Performance

The stock has a market cap of $552.37 million, a PE ratio of -18.66 and a beta of 1.16. The firm's 50-day moving average price is $27.07 and its two-hundred day moving average price is $29.57. The company has a current ratio of 7.17, a quick ratio of 1.96 and a debt-to-equity ratio of 0.19.

Insider Activity

In other news, General Counsel Daniel J. Gerritzen sold 10,000 shares of the stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $29.30, for a total value of $293,000.00. Following the sale, the general counsel now owns 77,304 shares in the company, valued at $2,265,007.20. This represents a 11.45 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 31.80% of the company's stock.

Hedge Funds Weigh In On OrthoPediatrics

Large investors have recently made changes to their positions in the company. Quarry LP acquired a new position in shares of OrthoPediatrics during the 3rd quarter worth approximately $25,000. International Assets Investment Management LLC raised its position in OrthoPediatrics by 2,610.8% during the third quarter. International Assets Investment Management LLC now owns 1,003 shares of the company's stock worth $27,000 after acquiring an additional 966 shares during the period. Quest Partners LLC purchased a new position in OrthoPediatrics during the second quarter valued at $34,000. EntryPoint Capital LLC grew its position in shares of OrthoPediatrics by 56.9% in the first quarter. EntryPoint Capital LLC now owns 2,783 shares of the company's stock valued at $81,000 after purchasing an additional 1,009 shares during the period. Finally, BNP Paribas Financial Markets increased its stake in shares of OrthoPediatrics by 125.1% during the third quarter. BNP Paribas Financial Markets now owns 3,471 shares of the company's stock worth $94,000 after purchasing an additional 1,929 shares in the last quarter. 69.05% of the stock is currently owned by institutional investors and hedge funds.

About OrthoPediatrics

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.